Smoking marijuana for neuropathic Pain: Results from an investigative study show that inhaling marijuana has a significant impact on neuropathic discomfort that appears to be dose dependent, in the first published study on cannabinoids for painful diabetic neuropathy in humans.
Research that was published in The Journal of Pain, researchers out of the University of California, San Diego conducted a randomized, double-blind, placebo-controlled crossover research of 16 patients with painful diabetic neuropathy to determine the short-term effectiveness and tolerability of inhaled marijuana.
Each person who participated in the investigative study was exposed to four single dosing sessions of low doses of marijuana or placebo. Baseline spontaneous and evoked discomfort were measured, and cognitive trials were conducted; the subjects then received aerosolized marijuana or placebo and the intensity of discomfort and subjective “highness” score was gauged at 5, 15, 30, 45, and 60 minutes and then very half hour for an additional three hours.
When measuring the impact of inhaled marijuana impact on realization, the researchers discovered most effects with no severe declines or impairments. Even though all participants experiencing euphoria or somnolence, which may cap the acceptability of marijuana as an analgesic, the authors arrive at the conclusion that marijuana could still offer advantages in neuropathic pain syndromes that involve treatment refractory diabetic neuropathy.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
